+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report by Molecule Type, by Drug Development Type, by Formulation, by Routes of Administration, by Sales Channel, by Age Group, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 170 Pages
  • July 2021
  • Region: Global
  • Grand View Research
  • ID: 5415469
The global pharmaceutical manufacturing market size is expected to reach USD 957.59 billion by 2028, registering a CAGR of 11.34% over the forecast years. The presence of supportive regulatory legislations, patentability norms, and high funding and investments in the pharmaceutical industry are anticipated to drive market growth. In addition, the broadening of preventive care has created significant opportunities in the market.





The high burden of diseases, economic growth leading to a rise in disposable incomes, improvements in healthcare infrastructure, better healthcare financing, and a rise in the geriatric population have spurred the demand for pharmaceutical manufacturing techniques in biotechnology and pharmaceutical companies. These factors have also prompted many individuals to use medications to improve their quality of life and wellness. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues for pharmaceutical manufacturers to accelerate their drug production.

Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize production costs, overcome medicine shortages, and improve efficiencies. For instance, in March 2021, CONTINUUS Pharmaceuticals announced the construction of the first GMP facility using continuous manufacturing equipment. The company has received a contract from the U.S. government for the production of finished dosage forms and critical APIs. North America accounted for the highest revenue share in 2029 as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers.

Pharmaceutical Manufacturing Market Report Highlights

  • Conventional drug manufacturing captured a significant revenue share in 2020 owing to the high penetration of small molecules in terms of usage. An increasing number of regulatory approvals has also positively impacted the segment growth
  • Outsource drug development accounted for the largest revenue share in 2020 due to continuous efforts undertaken by the key service providers to expand their production capacities
  • The Over-the-Counter (OTC) medicines segment is anticipated to grow at the fastest CAGR from 2021 to 2028 due to the continuous transition from prescription to OTC. This shift from prescription medicines to OTC medicines has potentially benefitted the patients both financially and in terms of better health
  • The children & adolescents segment is expected to grow at the fastest CAGR from 2021 to 2028 due to the presence of supportive government initiatives that encourage pediatric studies. The Pediatric Research Equity Act and Best Practices for Children Act are among the few initiatives of the FDA that focus on the development of drugs for children
  • The retail sale channel segment held the maximum revenue share as a large percentage of individuals use a retail pharmacy as their one-stop-shop for pharmaceutical products


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Pharmaceutical Manufacturing Market

What is the estimated value of the Pharmaceutical Manufacturing Market?

The Pharmaceutical Manufacturing Market was estimated to be valued at $486.6 billion in 2021.

What is the growth rate of the Pharmaceutical Manufacturing Market?

The growth rate of the Pharmaceutical Manufacturing Market is 10.2%, with an estimated value of $957.6 billion by 2028.

What is the forecasted size of the Pharmaceutical Manufacturing Market?

The Pharmaceutical Manufacturing Market is estimated to be worth $957.6 billion by 2028.

Who are the key companies in the Pharmaceutical Manufacturing Market?

Key companies in the Pharmaceutical Manufacturing Market include ASTRAZENECA, F. HOFFMANN, LA ROCHE LTD., THERMO FISHER SCIENTIFIC, INC., WUXI APPTEC, SAMSUNG BIOLOGICS, FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC., LONZA and CATALENT PHARMA SOLUTIONS.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 List of Secondary Sources
1.9 List of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Pharmaceutical Manufacturing Market: Market Outlook
2.2 Pharmaceutical Manufacturing Market: Market Segmentation
2.3 Pharmaceutical Manufacturing Market: Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping for Route of Administration, 2020
3.2 Pharmaceutical Manufacturing: Pipeline Analysis
3.3 Pharmaceutical Manufacturing: Medicine Usage and Spending
3.4 Pharmaceutical Manufacturing Market: Impact of COVID-19 Infection
3.4.1 Effects On Supply Chain
3.4.2 Distribution And Logistics Concerns
3.4.3 Pharma Research Into COVID-19
3.5 Pharmaceutical Manufacturing: Regulatory Framework
3.5.1 Regulatory Framework In the U.S.
3.5.2 Regulatory Framework in the Europe
3.5.3 Regulatory Framework in China
3.5.4 Regulatory Framework in India
3.5.5 Regulatory Framework in Brazil
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Rise in pharmaceutical R&D spending
3.6.1.2 Advancements in pharmaceutical manufacturing technologies
3.6.1.3 Rise in focus toward healthcare needs IN emerging nations
3.6.1.4 increase in geriatric population and incidence of chronic disorders
3.6.2 Market Restraint Analysis
3.6.2.1 Patent expiration of most profiTable drugs
3.6.2.2 Pricing pressures on bio/pharmaceutical companies
3.6.3 Market Challenge Analysis
3.6.3.1 Challenges pertaining pharma supply chain
3.6.3.2 Lack of skilled professionals
3.6.4 Market Opportunity Analysis
3.6.4.1 Increase in number of clinical trials
3.6.4.2 increasing Investment and funding programs in pharmaceutical manufacturing industry
3.7 Business Environment Analysis
3.7.1 Pharmaceutical Manufacturing Market: Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.7.2 Porter’s Five Forces Analysis
3.8 Market Strategic Alliances
3.8.1 Agreement
3.8.2 Merger & acquisition
3.8.3 Partnership & collaboration
3.9 Market Entry Strategies
3.9.1 Entry strategies
3.9.2 Market entry strategies for small and mid-sized companies
Chapter 4 Molecule Type Business Analysis
4.1 Pharmaceutical Manufacturing Market: Molecule Type Movement Analysis
4.2 Biologics & Biosimilars (Large Molecules)
4.2.1 Global biologics & biosimilars (large molecules) manufacturing market, 2018 - 2028 (USD Billion)
4.3 Conventional Drugs (Small Molecules)
4.3.1 Global conventional drugs (small molecules) manufacturing market, 2018 - 2028 (USD Billion)
Chapter 5 Drug Development Type Business Analysis
5.1 Pharmaceutical Manufacturing Market: Drug Development Type Movement Analysis
5.2 In-house
5.2.1 Global in-house pharmaceutical manufacturing market, 2018 - 2028 (USD Billion)
5.3 Outsource
5.3.1 Global outsource pharmaceutical manufacturing market, 2018 - 2028 (USD Billion)
Chapter 6 Formulation Business Analysis
6.1 Pharmaceutical Manufacturing Market: Formulation Movement Analysis
6.2 Tablets
6.2.1 Global pharmaceutical manufacturing market for Tablets, 2018 - 2028 (USD Billion)
6.3 Capsules
6.3.1 Global pharmaceutical manufacturing market for capsules, 2018 - 2028 (USD Billion)
6.4 InjecTable
6.4.1 Global pharmaceutical manufacturing market for injecTable, 2018 - 2028 (USD Billion)
6.5 Sprays
6.5.1 Global pharmaceutical manufacturing market for sprays, 2018 - 2028 (USD Billion)
6.6 Suspensions
6.6.1 Global pharmaceutical manufacturing market for suspensions, 2018 - 2028 (USD Billion)
6.7 Powders
6.7.1 Global pharmaceutical manufacturing market for powders, 2018 - 2028 (USD Billion)
6.8 Other Formulations
6.8.1 Global pharmaceutical manufacturing market for other formulations, 2018 - 2028 (USD Billion)
Chapter 7 Routes Of Administration Business Analysis
7.1 Pharmaceutical Manufacturing Market: Routes of Administration Movement Analysis
7.2 Oral
7.2.1 Global pharmaceutical manufacturing market for oral route of administration, 2018 - 2028 (USD Billion)
7.3 Topical
7.3.1 Global pharmaceutical manufacturing market for topical route of administration, 2018 - 2028 (USD Billion)
7.4 Parenteral
7.4.1 Global pharmaceutical manufacturing market for parenteral route of administration, 2018 - 2028 (USD Billion)
7.5 Inhalations
7.5.1 Global pharmaceutical manufacturing market for inhalations route of administration, 2018 - 2028 (USD Billion)
7.6 Other Routes of Administration
7.6.1 Global pharmaceutical manufacturing market for other route of administration, 2018 - 2028 (USD Billion)
Chapter 8 Therapy Area Business Analysis
8.1 Pharmaceutical Manufacturing Market: Therapy Area Movement Analysis
8.2 Cardiovascular Diseases
8.2.1 Global pharmaceutical manufacturing market for cardiovascular diseases, 2018 - 2028 (USD Billion)
8.3 Pain
8.3.1 Global pharmaceutical manufacturing market for pain, 2018 - 2028 (USD Billion)
8.4 Diabetes
8.4.1 Global pharmaceutical manufacturing market for diabetes, 2018 - 2028 (USD Billion)
8.5 Cancer
8.5.1 Global pharmaceutical manufacturing market for cancer, 2018 - 2028 (USD Billion)
8.6 Respiratory Diseases
8.6.1 Global pharmaceutical manufacturing market for respiratory diseases, 2018 - 2028 (USD Billion)
8.7 Other Diseases
8.7.1 Global pharmaceutical manufacturing market for other diseases, 2018 - 2028 (USD Billion)
Chapter 9 Prescription Business Analysis
9.1 Pharmaceutical Manufacturing Market: Prescription Movement Analysis
9.2 Prescription Medicines
9.2.1 Global pharmaceutical manufacturing market for prescription medicines, 2018 - 2028 (USD Billion)
9.3 Over-the-Counter (OTC) Medicines
9.3.1 Global pharmaceutical manufacturing market for otc medicines, 2018 - 2028 (USD Billion)
Chapter 10 Age Type Business Analysis
10.1 Pharmaceutical Manufacturing Market: Age Type Movement Analysis
10.2 Children & Adolescents
10.2.1 Global pharmaceutical manufacturing market for children & adolescents, 2018 - 2028 (USD Billion)
10.3 Adults
10.3.1 Global pharmaceutical manufacturing market for adults, 2018 - 2028 (USD BILLION)
10.4 Geriatric
10.4.1 Global pharmaceutical manufacturing market for geriatric, 2018 - 2028 (USD Billion)
Chapter 11 Sales Channel Business Analysis
11.1 Pharmaceutical Manufacturing Market: Sales Channel Movement Analysis
11.2 Retail
11.2.1 Global pharmaceutical manufacturing market for retail channels, 2018 - 2028 (USD BILLION)
11.3 Non-retail
11.3.1 Global pharmaceutical manufacturing market for non-retail, 2018 - 2028 (USD Billion)
Chapter 12 Regional Business Analysis
12.1 Pharmaceutical Manufacturing Market: Regional Movement Analysis
12.2 North America
12.2.1 North America Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2028 (Usd Billion)
12.2.2 The U.S.
12.2.3.1 The U.S. pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.2.3.2 The U.S. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.2.3.3 The U.S. pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.2.3.4 The U.S. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.2.3.5 The U.S. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.2.3.6 The U.S. pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.2.3.7 The U.S. pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.2.3.8 The U.S. pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.2.3 Canada
12.2.3.1 Canada pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.2.3.2 Canada pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.2.3.3 Canada pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.2.3.4 Canada pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.2.3.5 Canada pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.2.3.6 Canada pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.2.3.7 Canada pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.2.3.8 Canada pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.3 Europe
12.3.1 Europe Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2028 (Usd Billion)
12.3.2 Germany
12.3.2.1 Germany pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.3.2.2 Germany pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.3.2.3 Germany pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.3.2.4 Germany pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.3.2.5 Germany pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.3.2.6 Germany pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.3.2.7 Germany pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.3.2.8 Germany pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.3.3 The U.K.
12.3.3.1 The U.K. pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.3.3.2 The U.K. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.3.3.3 The U.K. pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.3.3.4 The U.K. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.3.3.5 The U.K. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.3.3.6 UK pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.3.3.7 The U.K. pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.3.3.8 The U.K. pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.3.4 France
12.3.4.1 France pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.3.4.2 France pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.3.4.3 France pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.3.4.4 France pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.3.4.5 France pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.3.4.6 France pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.3.4.7 France pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.3.4.8 France pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.3.5 Spain
12.3.5.1 Spain pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.3.5.2 Spain pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.3.5.3 Spain pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.3.5.4 Spain pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.3.5.5 Spain pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.3.5.6 Spain pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.3.5.7 Spain pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.3.5.8 Spain pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.3.6 Italy
12.3.6.1 Italy pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.3.6.2 Italy pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.3.6.3 Italy pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.3.6.4 Italy pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.3.6.5 Italy pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.3.6.6 Italy pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.3.6.7 Italy pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.3.6.8 Italy pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.4 Asia Pacific
12.4.1 Asia Pacific Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2028 (Usd Billion)
12.4.2 Japan
12.4.2.1 Japan pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.4.2.2 Japan pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.4.2.3 Japan pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.4.2.4 Japan pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.4.2.5 Japan pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.4.2.6 Japan pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.4.2.7 Japan pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.4.2.8 Japan pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.4.3 China
12.4.3.1 China pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.4.3.2 China pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.4.3.3 China pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.4.3.4 China pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.4.3.5 China pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.4.3.6 China pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.4.3.7 China pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.4.3.8 China pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.4.4 India
12.4.4.1 India pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.4.4.2 India pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.4.4.3 India pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.4.4.4 India pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.4.4.5 India pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.4.4.6 India pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.4.4.7 India pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.4.4.8 India pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.5 Latin America
12.5.1 Latin America Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2028 (Usd Billion)
12.5.2 Brazil
12.5.2.1 Brazil pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.5.2.2 Brazil pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.5.2.3 Brazil pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.5.2.4 Brazil pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.5.2.5 Brazil pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.5.2.6 Brazil pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.5.2.7 Brazil pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.5.2.8 Brazil pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.5.3 Mexico
12.5.3.1 Mexico pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.5.3.2 Mexico pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.5.3.3 Mexico pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.5.3.4 Mexico pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.5.3.5 Mexico pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.5.3.6 Mexico pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.5.3.7 Mexico pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.5.3.8 Mexico pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.6 Middle East and Africa (MEA)
12.6.1 Mea Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2028 (Usd Billion)
12.6.2 South Africa
12.6.2.1 South Africa pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2028 (USD Billion)
12.6.2.2 South Africa pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.6.2.3 South Africa pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.6.2.4 South Africa pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.6.2.5 South Africa pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.6.2.6 South Africa pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.6.2.7 South Africa pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.6.2.8 South Africa pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
12.6.3 Saudi Arabia
12.6.3.1 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by molecule type,2018 - 2028 (USD Billion)
12.6.3.2 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2028 (USD Billion)
12.6.3.3 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2028 (USD Billion)
12.6.3.4 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2028 (USD Billion)
12.6.3.5 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2028 (USD Billion)
12.6.3.6 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2028 (USD Billion)
12.6.3.7 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2028 (USD Billion)
12.6.3.8 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2028 (USD Billion)
Chapter 13 Competitive Landscape
13.1 Recent Developments & Impact Analysis, by Key Market Participants
13.2 Public Companies
13.2.1 Top pharmaceutical companies
13.3 Private Companies
13.3.1 List of key emerging companies
13.4 Strategy Framework
13.5 Market Participation Categorization
13.6 Company Profiles
13.6.1 ASTRAZENECA
13.6.1.1 Company overview
13.6.1.2 Financial performance
13.6.1.3 Product benchmarking
13.6.1.4 Strategic initiatives
13.6.2 F. HOFFMANN-LA ROCHE LTD.
13.6.2.1 Company overview
13.6.2.2 Financial performance
13.6.2.3 Product benchmarking
13.6.2.4 Strategic initiatives
13.6.3 THERMO FISHER SCIENTIFIC, INC.
13.6.3.1 Company overview
13.6.3.2 Patheon
13.6.3.2.1 Company overview
13.6.3.2.2 DPx
13.6.3.3 Brammer Bio
13.6.3.3.1 Company overview
13.6.3.4 Financial performance
13.6.3.4.1 Financial performance
13.6.3.5 Product benchmarking
13.6.3.6 Strategic initiatives
13.6.4 WUXI APPTEC
13.6.4.1 Company overview
13.6.4.2 Wuxi Advanced Therapies
13.6.4.2.1 Company Overview
13.6.4.3 Financial performance
13.6.4.4 Product benchmarking
13.6.4.5 Strategic initiatives
13.6.5 SAMSUNG BIOLOGICS
13.6.5.1 Company overview
13.6.5.2 Financial performance
13.6.5.3 Product benchmarking
13.6.5.4 Strategic initiatives
13.6.6 FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
13.6.6.1 Company overview
13.6.6.2 Product benchmarking
13.6.6.3 Strategic initiatives
13.6.7 LONZA
13.6.7.1 Company overview
13.6.7.2 Financial performance
13.6.7.3 Product benchmarking
13.6.7.4 Strategic initiatives
13.6.8 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
13.6.8.1 Company overview
13.6.8.2 Financial performance
13.6.8.3 Product benchmarking
13.6.8.4 Strategic initiatives
13.6.9 CATALENT PHARMA SOLUTIONS
13.6.9.1 Company overview
13.6.9.2 Financial performance
13.6.9.3 Product benchmarking
13.6.9.4 Strategic initiatives
13.6.10 JUBILANT LIFE SCIENCES LIMITED
13.6.10.1 Company overview
13.6.10.2 Financial performance
13.6.10.3 Product benchmarking
13.6.10.4 Strategic initiatives
List of Tables
Table 1 Comparison of drug delivery technologies of ten advanced pharmaceutical technologies (1980 - 2017)
Table 2 Number of active drugs by diseases in 2019
Table 3 Therapy wise healthcare spending in developed and pharmerging nations in 2017 (USD Billion)
Table 4 Top ten most common prescribed drugs in the U.S.
Table 5 List of secondary sources include, but are not limited to:
Table 6 Number of pipeline products for top pharmaceutical companies
Table 7 Number of pipeline products for top pharmaceutical companies
Table 8 Major regulatory agencies globally
Table 9 Major Indian regulations for pharmaceuticals
Table 10 List of major drug patent expirations in 2019
Table 11 Major entry strategies
Table 12 Advantages and disadvantages of different routes of administration
Table 13 List of top cardiovascular drugs
Table 14 Recent pediatric labeling information
Table 15 North America pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 16 North America pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 17 North America pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 18 North America pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 19 North America pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 20 North America pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 21 North America pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 22 North America pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 23 The U.S. pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 24 The U. S. pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 25 The U.S. pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 26 The U.S. pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 27 The U.S. pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 28 The U.S. pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 29 The U.S. pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 30 The U.S. pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 31 Canada pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 32 Canada pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 33 Canada pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 34 Canada pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 35 Canada pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 36 Canada pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 37 Canada pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 38 Canada pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 39 Europe pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 40 Europe pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 41 Europe pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 42 Europe pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 43 Europe pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 44 Europe pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 45 Europe pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 46 Europe pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 47 Germany pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 48 Germany pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 49 Germany pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 50 Germany pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 51 Germany pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 52 Germany pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 53 Germany pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 54 Germany pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 55 The U.K. pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 56 The U.K. pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 57 The U.K. pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 58 The U.K. pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 59 The U.K. pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 60 The U.K. pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 61 The U.K. pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 62 The U.K. pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 63 France pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 64 France pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 65 France pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 66 France pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 67 France pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 68 France pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 69 France pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 70 France pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 71 Spain pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 72 Spain pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 73 Spain pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 74 Spain pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 75 Spain pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 76 Spain pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 77 Spain pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 78 Spain pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 79 Italy pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 80 Italy pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 81 Italy pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 82 Italy pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 83 Italy pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 84 Italy pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 85 Italy pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 86 Italy pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 87 Asia Pacific pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 88 Asia Pacific pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 89 Asia Pacific pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 90 Asia Pacific pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 91 Asia Pacific pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 92 Asia pacific pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 93 Asia Pacific pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 94 Asia Pacific pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 95 Japan pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 96 Japan pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 97 Japan pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 98 Japan pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 99 Japan pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 100 Japan pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 101 Japan pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 102 Japan pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 103 China pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 104 China pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 105 China pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 106 China pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 107 China pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 108 China pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 109 China pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 110 China pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 111 India pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 112 India pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 113 India pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 114 India pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 115 India pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 116 India pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 117 India pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 118 India pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 119 Latin America pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 120 Latin America pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 121 Latin America pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 122 Latin America pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 123 Latin America pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 124 Latin America pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 125 Latin America pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 126 Latin America pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 127 Brazil pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 128 Brazil pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 129 Brazil pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 130 Brazil pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 131 Brazil pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 132 Brazil pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 133 Brazil pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 134 Brazil pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 135 Mexico pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 136 Mexico pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 137 Mexico pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 138 Mexico pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 139 Mexico pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 140 Mexico pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 141 Mexico pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 142 Mexico pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 143 MEA pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 144 MEA pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 145 MEA pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 146 MEA pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 147 MEA pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 148 MEA pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 149 MEA pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 150 MEA pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 151 South Africa pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 152 South Africa pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 153 South Africa pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 154 South Africa pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 155 South Africa pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 156 South Africa pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 157 South Africa pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 158 South Africa pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 159 Saudi Arabia pharmaceutical manufacturing market, By molecule type, 2018 - 2028 (USD Billion)
Table 160 Saudi Arabia pharmaceutical manufacturing market, By drug development type, 2018 - 2028 (USD Billion)
Table 161 Saudi Arabia pharmaceutical manufacturing market, By formulation, 2018 - 2028 (USD Billion)
Table 162 Saudi Arabia pharmaceutical manufacturing market, By route of administration, 2018 - 2028 (USD Billion)
Table 163 Saudi Arabia pharmaceutical manufacturing market, By therapy area, 2018 - 2028 (USD Billion)
Table 164 Saudi Arabia pharmaceutical manufacturing market, By prescription requirements, 2018 - 2028 (USD Billion)
Table 165 Saudi Arabia pharmaceutical manufacturing market, By age type, 2018 - 2028 (USD Billion)
Table 166 Saudi Arabia pharmaceutical manufacturing market, By sales channel, 2018 - 2028 (USD Billion)
Table 167 List of key emerging drug developers
Table 168 List of contract manufacturers
List of Figures
Fig. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Development of active pharmaceutical ingredients (API) by type
FIG. 9 Distribution of different dosage formulations of oral and inhalation drug delivery technologies
FIG. 10 Analysis of different routes of administration of FDA-approval pharmaceutical products
FIG. 11 FDA drug approvals by route of administration from 2015 to 2018
FIG. 12 Estimated spending by therapy area in 2020 (in percentage)
FIG. 13 Prevalence rate of chronic disorders by age group
FIG. 14 Pharmaceutical manufacturing market segmentation
FIG. 15 Market snapshot (USD Billion)
FIG. 16 Penetration and growth prospect mapping for route of administration, 2020
FIG. 17 Total R&D pipeline size from 2001 to 2019
FIG. 18 Comparison of pipeline by phase for 2019 and 2018
FIG. 19 Pipeline analysis by therapy area, 2019 and 2018
FIG. 20 Medicine spending by region in 2015 and 2018 (USD Billion)
FIG. 21 Estimated medicine spending by region in 2023 for branded and OTC medicines (in percentage)
FIG. 22 New and estimated brand spending in developed markets from 2009 to 2023 (USD Billion)
FIG. 23 Specialty medicine spending by therapeutic area in 2018 and 2023 (in percentage)
FIG. 24 Upcoming trends in pharmaceutical industry
FIG. 25 FDA drug approval process
FIG. 26 Key milestones of EMA interaction with consumer
FIG. 27 Application for approval or clinical study in China (Step 1)
FIG. 28 Clinical trials in China (Step 2)
FIG. 29 Final approval for drug registration in China (Step 3)
FIG. 30 Brazil regulatory structure for drug development process
FIG. 31 Market trends & outlook
FIG. 32 Market driver relevance analysis (Current & future impact)
FIG. 33 R&D spending of top pharmaceutical companies in USD Billion
FIG. 34 Global pharmaceutical R&D spending from 2010 to 2024 in USD Billion
FIG. 35 Overview of Pharma 4.0 analytics
FIG. 36 Projected growth of pharmaceutical market in developed and pharmerging markets between 2018 and 2022
FIG. 37 Market restraint analysis
FIG. 38 Common pharmaceutical supply chain challenges
FIG. 39 Number of registered clinical trials from 2000 to 2020
FIG. 40 Global financings in cell therapy, 2016 - 2018
FIG. 41 SWOT analysis, by factor (Political & legal, economic, and technological)
FIG. 42 Porter’s Five Forces Analysis
FIG. 43 Comparison of market entry strategies with their trade-offs
FIG. 44 Components of a market entry solution
FIG. 45 Marketing channels
FIG. 46 Pharmaceutical manufacturing market: Molecule Type outlook and key takeaways
FIG. 47 Pharmaceutical manufacturing market: Molecule type movement analysis
FIG. 48 Global biologics & biosimilars (large molecules) manufacturing market, 2018 - 2028 (USD Billion)
FIG. 49 Global conventional drugs (small molecules) manufacturing market, 2018 - 2028 (USD Billion)
FIG. 50 Pharmaceutical manufacturing market: Type outlook and key takeaways
FIG. 51 Pharmaceutical manufacturing market: Drug development type movement analysis
FIG. 52 Advantages of in-house CRO & CMO
FIG. 53 Global in-house pharmaceutical manufacturing market, 2018 - 2028 (USD Billion)
FIG. 54 Outsourced manufacturing activities
FIG. 55 Global outsource pharmaceutical manufacturing market, 2018 - 2028 (USD Billion)
FIG. 56 Pharmaceutical manufacturing market: Formulation outlook and key takeaways
FIG. 57 Pharmaceutical manufacturing market: Formulation movement analysis
FIG. 58 Global pharmaceutical manufacturing market for Tablets, 2018 - 2028 (USD Billion)
FIG. 59 Global pharmaceutical manufacturing market for capsules, 2018 - 2028 (USD Billion)
FIG. 60 Global pharmaceutical manufacturing market for injecTable, 2018 - 2028 (USD Billion)
FIG. 61 Global pharmaceutical manufacturing market for sprays, 2018 - 2028 (USD Billion)
FIG. 62 Global pharmaceutical manufacturing market for suspensions, 2018 - 2028 (USD Billion)
FIG. 63 Global pharmaceutical manufacturing market for powders, 2018 - 2028 (USD Billion)
FIG. 64 Global pharmaceutical manufacturing market for other formulations, 2018 - 2028 (USD Billion)
FIG. 65 Pharmaceutical manufacturing market: Routes of administration outlook and key takeaways
FIG. 66 Pharmaceutical manufacturing market: Routes of administration movement analysis
FIG. 67 Global pharmaceutical manufacturing market for oral route of administration, 2018 - 2028 (USD Billion)
FIG. 68 Global pharmaceutical manufacturing market for topical route of administration, 2018 - 2028 (USD Billion)
FIG. 69 Global pharmaceutical manufacturing market for parenteral route of administration, 2018 - 2028 (USD Billion)
FIG. 70 Global pharmaceutical manufacturing market for inhalations route of administration, 2018 - 2028 (USD Billion)
FIG. 71 Global pharmaceutical manufacturing market for other route of administration, 2018 - 2028 (USD Billion)
FIG. 72 Pharmaceutical manufacturing market: Therapy area outlook and key takeaways
FIG. 73 Pharmaceutical manufacturing market: Therapy area movement analysis
FIG. 74 Global pharmaceutical manufacturing market for cardiovascular diseases, 2018 - 2028 (USD Billion)
FIG. 75 Global pharmaceutical manufacturing market for pain management, 2018 - 2028 (USD Billion)
FIG. 76 Global pharmaceutical manufacturing market for diabetes, 2018 - 2028 (USD Billion)
FIG. 77 Global pharmaceutical manufacturing market for cancer, 2018 - 2028 (USD Billion)
FIG. 78 Global pharmaceutical manufacturing market for respiratory diseases, 2018 - 2028 (USD Billion)
FIG. 79 Global pharmaceutical manufacturing market for other diseases, 2018 - 2028 (USD Billion)
FIG. 80 Pharmaceutical manufacturing market: Prescription outlook and key takeaways
FIG. 81 Pharmaceutical manufacturing market: Prescription movement analysis
FIG. 82 Total prescription drug expenditure in the U.S. from 2009 to 2019 (USD Billion)
FIG. 83 Percent of total health spending for retail prescription drugs, 2010 – 2027
FIG. 84 Estimated out-of-pocket spending on prescription drugs per person in USD
FIG. 85 Global pharmaceutical manufacturing market for prescription medicines, 2018 - 2028 (USD Billion)
FIG. 86 Factors affecting Rx-to-OTC Switch
FIG. 87 Components for successful Rx-to-OTC Switch
FIG. 88 Global pharmaceutical manufacturing market for OTC medicines, 2018 - 2028 (USD Billion)
FIG. 89 Pharmaceutical manufacturing market: Age type outlook and key takeaways
FIG. 90 Pharmaceutical manufacturing market: Age type movement analysis
FIG. 91 Global pharmaceutical manufacturing market children & adolescents, 2018 - 2028 (USD Billion)
FIG. 92 Global pharmaceutical manufacturing market for adults, 2018 - 2028 (USD Billion)
FIG. 93 Number of individuals aged 65 years or over by geographic region in 2019 and 2050 (In million)
FIG. 94 Global pharmaceutical manufacturing market for geriatric, 2018 - 2028 (USD Billion)
FIG. 95 Pharmaceutical manufacturing market: Sales channel outlook and key takeaways
FIG. 96 Pharmaceutical manufacturing market: Sales channel movement analysis
FIG. 97 Global pharmaceutical manufacturing market retail channels, 2018 - 2028 (USD Billion)
FIG. 98 Global pharmaceutical manufacturing market for non-retail, 2018 - 2028 (USD Billion)
FIG. 99 Pharmaceutical manufacturing market: Regional outlook and key takeaways
FIG. 100 Pharmaceutical manufacturing market: Regional movement analysis
FIG. 101 North America pharmaceutical manufacturing market overview
FIG. 102 North America pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 103 The U.S. pharmaceutical manufacturing market overview
FIG. 104 The U.S. pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 105 Canada pharmaceutical manufacturing market overview
FIG. 106 Canada pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 107 Europe pharmaceutical manufacturing market overview
FIG. 108 Europe pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 109 Germany pharmaceutical manufacturing market overview
FIG. 110 Germany pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 111 The U.K. pharmaceutical manufacturing market overview
FIG. 112 The U.K. pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 113 France pharmaceutical manufacturing market overview
FIG. 114 France pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 115 Spain pharmaceutical manufacturing market overview
FIG. 116 Spain pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 117 Italy pharmaceutical manufacturing market overview
FIG. 118 Italy pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 119 Asia Pacific pharmaceutical manufacturing market overview
FIG. 120 Asia Pacific pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 121 Japan pharmaceutical manufacturing market overview
FIG. 122 Japan pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 123 China pharmaceutical manufacturing market overview
FIG. 124 China pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 125 India pharmaceutical manufacturing market overview
FIG. 126 India pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 127 Latin America pharmaceutical manufacturing market overview
FIG. 128 Latin America pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 129 Brazil pharmaceutical manufacturing market overview
FIG. 130 Brazil pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 131 Mexico pharmaceutical manufacturing market overview
FIG. 132 Mexico pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 133 Middle East & Africa (MEA) pharmaceutical manufacturing market overview
FIG. 134 MEA pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 135 South Africa pharmaceutical manufacturing market overview
FIG. 136 South Africa pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 137 Saudi Arabia pharmaceutical manufacturing market overview
FIG. 138 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, 2018 - 2028 (USD Billion)
FIG. 139 Recent developments & impact analysis, by key market participants
FIG. 140 Impact analysis of new developments by key market participants
FIG. 141 Comparison of pharmaceutical sales of top pharma companies, 2019 (In USD Billion)
FIG. 142 Strategy framework
FIG. 143 Market participation categorization

Companies Mentioned

  • ASTRAZENECA
  • F. HOFFMANN-LA ROCHE LTD.
  • THERMO FISHER SCIENTIFIC, INC.
  • WUXI APPTEC
  • SAMSUNG BIOLOGICS
  • FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
  • LONZA
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
  • CATALENT PHARMA SOLUTIONS
  • JUBILANT LIFE SCIENCES LIMITED

Methodology

Loading
LOADING...